MED12 and pregnancy disorder: These results support that the MED12‐LS domain plays a major role in the negative regulation of Gli3‐dependent SHH signaling (Zhou et al., 2012), and these mutations found in patients with ID and congenital malformations show deleterious effects on MED12 function.